Anti-SLC25A20 monoclonal antibody
Pre-made anti-SLC25A20 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SLC25A20/SLC25A20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1669-Ab-1/ GM-Tg-hg-IP1669-Ab-2 | Anti-Human SLC25A20 monoclonal antibody | Human |
GM-Tg-rg-IP1669-Ab-1/ GM-Tg-rg-IP1669-Ab-2 | Anti-Rat SLC25A20 monoclonal antibody | Rat |
GM-Tg-mg-IP1669-Ab-1/ GM-Tg-mg-IP1669-Ab-2 | Anti-Mouse SLC25A20 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1669-Ab-1/ GM-Tg-cynog-IP1669-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC25A20 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1669-Ab-1/ GM-Tg-felg-IP1669-Ab-2 | Anti-Feline SLC25A20 monoclonal antibody | Feline |
GM-Tg-cang-IP1669-Ab-1/ GM-Tg-cang-IP1669-Ab-2 | Anti-Canine SLC25A20 monoclonal antibody | Canine |
GM-Tg-bovg-IP1669-Ab-1/ GM-Tg-bovg-IP1669-Ab-2 | Anti-Bovine SLC25A20 monoclonal antibody | Bovine |
GM-Tg-equg-IP1669-Ab-1/ GM-Tg-equg-IP1669-Ab-2 | Anti-Equine SLC25A20 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1669-Ab-1/ GM-Tg-hg-IP1669-Ab-2; GM-Tg-rg-IP1669-Ab-1/ GM-Tg-rg-IP1669-Ab-2; GM-Tg-mg-IP1669-Ab-1/ GM-Tg-mg-IP1669-Ab-2; GM-Tg-cynog-IP1669-Ab-1/ GM-Tg-cynog-IP1669-Ab-2; GM-Tg-felg-IP1669-Ab-1/ GM-Tg-felg-IP1669-Ab-2; GM-Tg-cang-IP1669-Ab-1/ GM-Tg-cang-IP1669-Ab-2; GM-Tg-bovg-IP1669-Ab-1/ GM-Tg-bovg-IP1669-Ab-2; GM-Tg-equg-IP1669-Ab-1/ GM-Tg-equg-IP1669-Ab-2 |
Products Name | Anti-SLC25A20 monoclonal antibody |
Format | mab |
Target Name | SLC25A20 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SLC25A20 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1669-Ag-1 | Recombinant multi-species MCAT/ SLC25A20/ CAC protein |
Target information
Target ID | GM-IP1669 |
Target Name | SLC25A20 |
Gene ID | 788,57279,117035,709029,101100874,518758,100063527 |
Gene Symbol and Synonyms | 1110007P09Rik,CAC,CACT,mCAC,SLC25A20 |
Uniprot Accession | O43772,P97521 |
Uniprot Entry Name | MCAT_HUMAN,MCAT_RAT |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000178537 |
Target Classification | N/A |
The target: SLC25A20, gene name: SLC25A20, also named as CAC, CACT. This gene product is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space. This protein mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.